| Name | Nurulimab |
|---|
| Description | Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |